Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DYADIC INTERNATIONAL INCDYAI · Entity 7611 | Director | June 11, 2024 | June 13, 2024 |
| Enumeral Biomedical Holdings, Inc.ENUM · Entity 179878 | Director | December 09, 2016 | December 13, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DYADIC INTERNATIONAL INC
Report date June 11, 2024 · Filed June 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,967 |
Reported balance
After 2024-06-11 transaction · row 1
1 source rowRow 1 · 2024-06-11 · Exercise / conversion · Acquired 11,793 · Balance 38,967 F1: The restricted stock units vested upon retirement from service as a member of the board of directors. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 38,967 |
Reported balance
After 2024-06-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-06-11 · Exercise / conversion · Disposed 11,793 · Balance 38,967 F1: The restricted stock units vested upon retirement from service as a member of the board of directors. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 38,967 |
Reported balance
After 2024-06-11 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-06-11 · Disposition to issuer · Disposed 11,792 · Balance 38,967 F2: The restricted stock units were forfeited upon retirement from service as a member of the board of directors. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units vested upon retirement from service as a member of the board of directors.
F2: The restricted stock units were forfeited upon retirement from service as a member of the board of directors.
Enumeral Biomedical Holdings, Inc.
Report date December 09, 2016 · Filed December 13, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 120,882 |
Reported balance
After 2016-12-09 transaction · row 1
1 source rowRow 1 · 2016-12-09 · Exercise / conversion · Acquired 52,000 · Balance 120,882 |
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $2.00 · Expires 2019-07-30 | Direct | 13,000 |
Reported balance
After 2016-12-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-12-09 · Purchase · Acquired 13,000 · Balance 13,000 F2: The Reporting Person acquired the reported Warrants in a private sale transaction for cash consideration in the amount of $0.08 per warrant. F1: The Common Stock Purchase Warrants (the "Warrants") are exercisable immediately. |
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.50 · Expires 2016-12-09 | Direct | 52,000 |
Reported balance
After 2016-12-09 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2016-12-09 · Other · Acquired 52,000 · Balance 52,000 F3: Pursuant to an Offer to Amend and Exercise launched by the Issuer on October 28, 2016 (as subsequently amended, the "Offering"), the exercise price of each Warrant tendered in the Offering was reduced to $0.50 per Warrant, and participants in the Offering received four shares for each Warrant tendered rather than one share. Pursuant to the terms of the Offering, the expiration date of tendered Warrants was accelerated to December 9, 2016. The Reporting Person tendered all of the Warrants beneficially owned in the Offering. F1: The Common Stock Purchase Warrants (the "Warrants") are exercisable immediately. |
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.50 · Expires 2016-12-09 | Direct | 0 |
Reported balance
After 2016-12-09 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2016-12-09 · Exercise / conversion · Disposed 52,000 · Balance 0 F3: Pursuant to an Offer to Amend and Exercise launched by the Issuer on October 28, 2016 (as subsequently amended, the "Offering"), the exercise price of each Warrant tendered in the Offering was reduced to $0.50 per Warrant, and participants in the Offering received four shares for each Warrant tendered rather than one share. Pursuant to the terms of the Offering, the expiration date of tendered Warrants was accelerated to December 9, 2016. The Reporting Person tendered all of the Warrants beneficially owned in the Offering. F1: The Common Stock Purchase Warrants (the "Warrants") are exercisable immediately. |
| Common StockSEC Table I · non-derivative | IndirectBy BiologicB, LLC | 175,286 |
Reported balance
Holding disclosure · report date 2016-12-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 175,286 |
Filing footnotes · ownership attribution and instrument terms
F1: The Common Stock Purchase Warrants (the "Warrants") are exercisable immediately.
F2: The Reporting Person acquired the reported Warrants in a private sale transaction for cash consideration in the amount of $0.08 per warrant.
F3: Pursuant to an Offer to Amend and Exercise launched by the Issuer on October 28, 2016 (as subsequently amended, the "Offering"), the exercise price of each Warrant tendered in the Offering was reduced to $0.50 per Warrant, and participants in the Offering received four shares for each Warrant tendered rather than one share. Pursuant to the terms of the Offering, the expiration date of tendered Warrants was accelerated to December 9, 2016. The Reporting Person tendered all of the Warrants beneficially owned in the Offering.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2024 Filed Jun 13, 2024 21:26 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | Disposition to issuerRestricted Stock Unit · Derivative | 11,792 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-020246 · rdgdoc.xml · derivative · entry 3 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,967 Underlying: Common Stock · 11,792 shares Expires not disclosed F2 · shares: The restricted stock units were forfeited upon retirement from service as a member of the board of directors. F2 · derivative.expiration_date: The restricted stock units were forfeited upon retirement from service as a member of the board of directors. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:26 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | Exercise / conversionRestricted Stock Unit · Derivative | 11,793 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-020246 · rdgdoc.xml · derivative · entry 2 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,967 Underlying: Common Stock · 11,793 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock units vested upon retirement from service as a member of the board of directors. F1 · derivative.expiration_date: The restricted stock units vested upon retirement from service as a member of the board of directors. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:26 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | Exercise / conversionCommon Stock | 11,793 | $1.59 | $18,750.87 |
DisclosureSEC source: 0001437749-24-020246 · rdgdoc.xml · nonDerivative · entry 1 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units vested upon retirement from service as a member of the board of directors. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 20:02 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | Exercise / conversionRestricted Stock Unit · Derivative | 27,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-000649 · rdgdoc.xml · derivative · entry 4 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,174 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The restricted stock units previously issued and vested upon one year of service were settled 100% in Issuer's common stock. F5 · derivative.expiration_date: The restricted stock units previously issued and vested upon one year of service were settled 100% in Issuer's common stock. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 20:02 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | Exercise / conversionCommon Stock | 27,174 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-000649 · rdgdoc.xml · nonDerivative · entry 1 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 20:02 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GrantRestricted Stock Unit · Derivative | 23,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-000649 · rdgdoc.xml · derivative · entry 3 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,585 Underlying: Common Stock · 23,585 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · kind: Receipt of restricted stock units as a result of reduction in directors' cash compensation. F4 · derivative.exercise_date: The restricted stock units will be settled 100% in Issuer's common stock when vested upon one year of service as a member of the board of directors. F4 · derivative.expiration_date: The restricted stock units will be settled 100% in Issuer's common stock when vested upon one year of service as a member of the board of directors. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 20:02 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GrantStock Option · Derivative | 50,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001437749-24-000649 · rdgdoc.xml · derivative · entry 2 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-01-02 F2 · shares: Annual grant of stock options. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 19:28 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GrantRestricted Stock Unit · Derivative | 27,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-000576 · rdgdoc.xml · derivative · entry 2 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,174 Underlying: Common Stock · 27,174 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · kind: Receipt of restricted stock units as a result of reduction in director cash compensation. F4 · derivative.exercise_date: The restricted stock units will be settled 100% in Issuer's common stock when vested upon one year of service as board of director. F4 · derivative.expiration_date: The restricted stock units will be settled 100% in Issuer's common stock when vested upon one year of service as board of director. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 19:28 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GrantStock Option · Derivative | 35,000 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001437749-23-000576 · rdgdoc.xml · derivative · entry 1 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-01-02 F1 · shares: Annual grant of stock options. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 16:10 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GrantStock Option · Derivative | 25,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001437749-22-014959 · rdgdoc.xml · derivative · entry 1 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-09 F1 · shares: Grant of stock options as a result of a reduction in director cash compensation. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 17:33 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GrantStock Option · Derivative | 35,000 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001437749-22-000460 · rdgdoc.xml · derivative · entry 1 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-01-02 F1 · shares: Annual grant of stock options. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 17:23 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GrantStock Option · Derivative | 35,000 | $0.00 Strike: $5.16 | $0.00 |
DisclosureSEC source: 0001437749-21-000291 · rdgdoc.xml · derivative · entry 1 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2031-01-03 F1 · shares: Annual grant of stock options. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 20:49 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | GrantStock Option · Derivative | 50,000 | $0.00 Strike: $5.27 | $0.00 |
DisclosureSEC source: 0001213809-20-000004 · wf-form4_157810253390992.xml · derivative · entry 1 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-01-01 F1 · shares: Annual grant of stock options. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 20:10 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | Exercise / conversionStock Option · Derivative | 2,500 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001213809-19-000076 · wf-form4_157559463500438.xml · derivative · entry 5 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2028-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 20:10 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | Exercise / conversionStock Option · Derivative | 12,500 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001213809-19-000076 · wf-form4_157559463500438.xml · derivative · entry 4 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2028-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 20:10 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | SaleCommon Stock | 15,000 | $6.18 | $92,700.00 |
DisclosureSEC source: 0001213809-19-000076 · wf-form4_157559463500438.xml · nonDerivative · entry 3 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.17 to $6.22, inclusive. The reporting person undertakes to provide to Dyadic International, Inc., any security holder of Dyadic International, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of footnote (1) to this Form 4. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 20:10 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | Exercise / conversionCommon Stock | 2,500 | $1.39 | $3,475.00 |
DisclosureSEC source: 0001213809-19-000076 · wf-form4_157559463500438.xml · nonDerivative · entry 2 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 20:10 UTC | DYADIC INTERNATIONAL INC DYAI · Entity 7611 | Exercise / conversionCommon Stock | 12,500 | $1.39 | $17,375.00 |
DisclosureSEC source: 0001213809-19-000076 · wf-form4_157559463500438.xml · nonDerivative · entry 1 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 17:35 UTC | Enumeral Biomedical Holdings, Inc. ENUM · Entity 179878 | Exercise / conversionCommon Stock Purchase Warrant · Derivative | 52,000 | $0.13 Strike: $0.50 | $6,500.00 |
DisclosureSEC source: 0001615774-16-008882 · s104937_form4.xml · derivative · entry 5 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,000 shares Expires 2016-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Pursuant to an Offer to Amend and Exercise launched by the Issuer on October 28, 2016 (as subsequently amended, the "Offering"), the exercise price of each Warrant tendered in the Offering was reduced to $0.50 per Warrant, and participants in the Offering received four shares for each Warrant tendered rather than one share. Pursuant to the terms of the Offering, the expiration date of tendered Warrants was accelerated to December 9, 2016. The Reporting Person tendered all of the Warrants beneficially owned in the Offering. F3 · price: Pursuant to an Offer to Amend and Exercise launched by the Issuer on October 28, 2016 (as subsequently amended, the "Offering"), the exercise price of each Warrant tendered in the Offering was reduced to $0.50 per Warrant, and participants in the Offering received four shares for each Warrant tendered rather than one share. Pursuant to the terms of the Offering, the expiration date of tendered Warrants was accelerated to December 9, 2016. The Reporting Person tendered all of the Warrants beneficially owned in the Offering. F1 · derivative.exercise_date: The Common Stock Purchase Warrants (the "Warrants") are exercisable immediately. F3 · derivative.expiration_date: Pursuant to an Offer to Amend and Exercise launched by the Issuer on October 28, 2016 (as subsequently amended, the "Offering"), the exercise price of each Warrant tendered in the Offering was reduced to $0.50 per Warrant, and participants in the Offering received four shares for each Warrant tendered rather than one share. Pursuant to the terms of the Offering, the expiration date of tendered Warrants was accelerated to December 9, 2016. The Reporting Person tendered all of the Warrants beneficially owned in the Offering. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 17:35 UTC | Enumeral Biomedical Holdings, Inc. ENUM · Entity 179878 | OtherCommon Stock Purchase Warrant · Derivative | 52,000 | $0.13 Strike: $0.50 | $6,500.00 |
DisclosureSEC source: 0001615774-16-008882 · s104937_form4.xml · derivative · entry 4 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2016-12-09 F3 · derivative.exercise_price: Pursuant to an Offer to Amend and Exercise launched by the Issuer on October 28, 2016 (as subsequently amended, the "Offering"), the exercise price of each Warrant tendered in the Offering was reduced to $0.50 per Warrant, and participants in the Offering received four shares for each Warrant tendered rather than one share. Pursuant to the terms of the Offering, the expiration date of tendered Warrants was accelerated to December 9, 2016. The Reporting Person tendered all of the Warrants beneficially owned in the Offering. F3 · price: Pursuant to an Offer to Amend and Exercise launched by the Issuer on October 28, 2016 (as subsequently amended, the "Offering"), the exercise price of each Warrant tendered in the Offering was reduced to $0.50 per Warrant, and participants in the Offering received four shares for each Warrant tendered rather than one share. Pursuant to the terms of the Offering, the expiration date of tendered Warrants was accelerated to December 9, 2016. The Reporting Person tendered all of the Warrants beneficially owned in the Offering. F1 · derivative.exercise_date: The Common Stock Purchase Warrants (the "Warrants") are exercisable immediately. F3 · derivative.expiration_date: Pursuant to an Offer to Amend and Exercise launched by the Issuer on October 28, 2016 (as subsequently amended, the "Offering"), the exercise price of each Warrant tendered in the Offering was reduced to $0.50 per Warrant, and participants in the Offering received four shares for each Warrant tendered rather than one share. Pursuant to the terms of the Offering, the expiration date of tendered Warrants was accelerated to December 9, 2016. The Reporting Person tendered all of the Warrants beneficially owned in the Offering. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 17:35 UTC | Enumeral Biomedical Holdings, Inc. ENUM · Entity 179878 | PurchaseCommon Stock Purchase Warrant · Derivative | 13,000 | $0.08 Strike: $2.00 | $1,040.00 |
DisclosureSEC source: 0001615774-16-008882 · s104937_form4.xml · derivative · entry 3 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2019-07-30 F2 · price: The Reporting Person acquired the reported Warrants in a private sale transaction for cash consideration in the amount of $0.08 per warrant. F1 · derivative.exercise_date: The Common Stock Purchase Warrants (the "Warrants") are exercisable immediately. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 17:35 UTC | Enumeral Biomedical Holdings, Inc. ENUM · Entity 179878 | Exercise / conversionCommon Stock | 52,000 | $0.13 | $6,500.00 |
DisclosureSEC source: 0001615774-16-008882 · s104937_form4.xml · nonDerivative · entry 1 Buckland Barry · CIK 0001618328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.